- $118.69m
- $79.25m
- $49.69m
- 79
- 91
- 12
- 64
Annual income statement for AMREP, fiscal year end - April 30th, USD millions except per share, conversion factor applied.
2021 April 30th | C2022 April 30th | 2023 April 30th | 2024 April 30th | 2025 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 40.1 | 58.9 | 48.7 | 51.4 | 49.7 |
Cost of Revenue | |||||
Gross Profit | 14.5 | 26.7 | 18.9 | 14.5 | 19.4 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 30.7 | 37.6 | 42.8 | 43.8 | 37.6 |
Operating Profit | 9.35 | 21.3 | 5.83 | 7.6 | 12.1 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10 | 21.6 | 7.64 | 8.43 | 13.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.39 | 15.9 | 21.8 | 6.69 | 12.7 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.39 | 15.9 | 21.8 | 6.69 | 12.7 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.39 | 15.9 | 21.8 | 6.69 | 12.7 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.923 | 2.2 | 5.04 | 1.25 | 2.37 |